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Abstract
Background: Claudins are major components of tight junctions, which form the paracellular barrier between the
cochlear luminal and abluminal fluid compartments that supports the large transepithelial voltage difference and
the large concentration differences of K+, Na+ and Ca2+ needed for normal cochlear function. Claudins are a family
of more than 20 subtypes, but our knowledge about expression and localization of each subtype in the cochlea is
limited.
Results: We examined by quantitative RT-PCR the expression of the mRNA of 24 claudin isoforms in mouse cochlea
during postnatal development and localized the expression in separated fractions of the cochlea. Transcripts of 21
claudin isoforms were detected at all ages, while 3 isoforms (Cldn-16, − 17 and − 18) were not detected. Claudins
that increased expression during development include Cldn-9, − 13, − 14, − 15, and -19v2, while Cldn-6 decreased.
Those that do not change expression level during postnatal development include Cldn-1, − 2, − 3, − 4, − 5, − 7, − 8,
−10v1, −10v2, − 11, − 12, −19v1, − 20, − 22, and − 23. Our investigation revealed unique localization of some
claudins. In particular, Cldn-13 expression rapidly increases during early development and is mainly expressed in
bone but only minimally in the lateral wall (including stria vascularis) and in the medial region (including the organ
of Corti). No statistically significant changes in expression of Cldn-11, − 13, or − 14 were found in the cochlea of
Slc26a4−/− mice compared to Slc26a4+/− mice.
Conclusions: We demonstrated developmental patterns of claudin isoform transcript expression in the murine
cochlea. Most of the claudins were associated with stria vascularis and organ of Corti, tissue fractions rich in tight
junctions. However, this study suggests a novel function of Cldn-13 in the cochlea, which may be linked to cochlear
bone marrow maturation.
Keywords: Tight junctions, Inner ear, Pendrin, SLC26A4, Mouse
Background
Tight junctions are structures consisting of proteins that
join epithelial and endothelial cells to form continuous
sheets and tubules which separate two liquid compart-
ments. They consist of claudins [1], occludins [2] and
other proteins that form a band-like network known as
tight junction strands. These junctions are known to
perform several functions (barrier, pore and fence), and
are composed of several types of proteins: transmem-
brane (e.g., claudins and occludin), cytoplasmic, signal-
ing and adapter links to the cytoskeleton [1, 3]. Barrier
function refers to the restriction of paracellular move-
ment of fluid constituents between the two fluid
compartments that are separated by the cell layer. Pore
function refers to the selective permeability of the para-
cellular barrier to those solutes that can pass between
the fluid compartments. The fence function refers to the
restriction of lateral movement of membrane proteins
and lipids within the face of the plasma membrane,
which retains the separate physiological functions of the
luminal and abluminal cell membranes that are neces-
sary to carry out vectorial transport of solutes and water.
Claudins are a family of more than 20 subtypes [1].
The specific isoforms of claudin included in a tight junc-
tion are the primary determinant of paracellular perme-
ability [3]. Common structures of the claudin family
include four transmembrane domains and two extracel-
lular loops (Fig. 1). It is thought that charged amino
acids in the first extracellular loop define the
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permeability of tight junctions, while the second extra-
cellular loop contributes toward adhesion of the apposed
cell membranes (Fig. 1) [1, 4]. Multiple claudin isoforms
are usually co-expressed in one tissue and their mixing
ratio determines the permeability properties of the tight
junction in that tissue [1, 5]. Claudins are regulated in
their expression, same-cell and neighboring-cell interac-
tions, modulations and degradation by numerous separ-
ate pathways and networks [3].
Claudins are known to be critical for normal hearing
[6, 7]. A major driving force for the ionic currents
underlying the cellular transduction of sound into corre-
sponding electrical signals to hearing centers in the
brain is the endocochlear potential, the transepithelial
voltage across the inner ear epithelium [8]. This voltage
is generated within the multi-layered stria vascularis in
the cochlear lateral wall and originates as a potential dif-
ference across the basal cell layer of the stria between
the intrastrial fluid space and the perilymph pervading
the fibrous spiral ligament [8]. This potential difference
across the basal cell layer is supported by the barrier
function of the highly dense tight junctions between the
basal cells, as confirmed by the reduction of endoco-
chlear potential and the resulting deafness in adult
Cldn-11 knockout mice [6]. In contrast to this pathology
of stria vascularis, mutation of Cldn-14 led to
degeneration of a different cochlear structure, the sen-
sory organ of Corti, and was associated with the human
hereditary deafness DFNB29 [9, 10]. It is to be expected
that mutations of other claudin isoforms in the cochlea
could lead to impaired hearing. In addition to these ex-
amples of claudin isoform localization and expression,
three other groups of investigators have reported expres-
sion of claudins in the cochlea [11–13]. Kitajiri and col-
leagues [12] examined Cldn-1 to Cldn-18 using
immunohistochemistry, but their study was limited by a
lack of antibodies for some claudins. We localized in the
current study transcript expression of most of the clau-
din isoforms in multiple tissue fractions of the cochlea,
including the outer layer of cochlear bone.
One of the most common hereditary deafness genes is
pendrin (SLC26A4), which has been surprisingly shown
to exert its strongest effects on cochlear function by ex-
pression in the endolymphatic sac during early develop-
ment [14]. Lack of pendrin expression was found to be
accompanied by delays in cochlear bone development
and in expression of other genes due to an apparent
local hypothyroidism [15]. It therefore was of interest to
determine whether the expression of Cldn-13, observed
in the present study to be predominantly expressed in
the outer bone fraction, would be altered by deletion of
the Slc26a4 gene in the mouse model.
The aim in the present study was to determine a) ex-
pression of claudin transcripts during early development,
b) localization of the claudin isoforms among the coch-
lear regions and c) the potential effects of Slc26a4
knockout on claudin isoform expression.
Methods
Slc26a4+/− and Slc26a4−/− mice were obtained from a
colony at Kansas State university and the heterozygous
mice served as controls. Animals were deeply anesthe-
tized with sodium pentobarbital (100 mg/kg i.p.). Tem-
poral bones were removed from both male and female
mice and whole cochleae were collected from age-sex
matched littermates of Slc26a4+/− and Slc26a4−/−. Ex-
pression of claudins was determined on RNA isolated
from a) whole cochlea, b) cochlear lateral wall tissues, c)
cochlear medial fraction tissues, and d) outer cochlear
bone. Lateral wall tissues were further microdissected
into spiral ligament and stria vascularis fractions, while
the medial fraction was further microdissected into
organ of Corti and modiolus fractions. All procedures
involving animals were approved by the Institutional
Animal Care and Use Committee of Kansas State Uni-
versity (protocol 2925).
Total RNA was isolated from these tissues using the
RNeasy Micro Kit (Qiagen, Valencia, CA; Cat #7400)
and care was taken that RNA was extracted from all cell
types. Recombinant bovine DNase I, Grade 1 (Roche
Fig. 1 Schematic diagram of claudin structure. Left panel. Apposed
epithelial cell membranes with one integral-membrane claudin
molecule in each cell. Each claudin has four transmembrane segments
including two extracellular loops and both the C-terminal and
N-terminal ends within the cytoplasm. The extracellular loops of
the apposed claudins associate with the respective loops of the
adjacent claudin. The right panel depicts each claudin molecule
as a sphere within the adjacent cell membranes, represented at
a lower magnification than in the left panel. Ion selectivity is
imparted to the tight junction by claudin amino acids with a
net charge in the first extracellular loop
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Diagnostics Corp, Indianapolis, IN; catalog #
04536282001) was used to remove residual DNA. The
quality and quantity of 18S rRNA were determined by
using the RNA 6000 Nano Kit (Agilent Technologies,
Santa Clara, CA; catalog # 5067–1511) with a Bioanaly-
zer (Agilent Technologies; Model 2100) and a spectro-
photometer (Thermo Scientific, Wilmington, DE;
NanoDrop 8000). The amount of RNA in each sample
was calculated as the average of the results of the Bioa-
nalyzer and NanoDrop assays.
Primer pairs for mouse Cldn-1 to − 23 (excluding
Cldn-21) were designed using software Primer3 (http://
primer3.sourceforge.net/). The sequences of primers are
documented in Table 1 and were validated with RNA
from positive control tissues (tibia, liver, lung, intestine,
kidney, stomach, skin, brain). mRNA expression was
measured by quantitative RT-PCR using a Bio-Rad icy-
cler iQ thermocycler and QuantiTect SYBR Green RT-
PCR Kit (Qiagen; catalog # 204243). Claudin mRNA was
normalized against 18S. The calculation method has
been described previously [16]. Melting curve measure-
ments were made with the Bio-Rad thermocycler and
the PCR product size was measured by using a DNA
assay (Agilent DNA 1000 Kit; catalog #5067–1504) on
the Agilent Bioanalyzer to exclude the detection of non-
specific PCR products. This method yields quantitative
measures of claudin isoform transcript expression that
can be compared within each isoform; however, compar-
isons between and among isoforms are not quantitative
in these experiments due to undetermined efficiencies in
the RT step that vary for each primer pair [16].
Data are given as means ± standard deviation (SD) or
± standard error of the mean (SEM), as reported in Re-
sults. N values refer to the number of cochleae (Figs. 2
and 4) or to the number of isolated tissues (Fig. 3a and
b) which are the same as the numbers of RT-PCR reac-
tions analyzed. A one-way analysis of variance (ANOVA)
with Holm-Sidak method post-test (Figs. 2 and 3) or a
two-way ANOVA which tested for statistical significance
of interaction between age and genotype. Since no statis-
tically significant interaction was found for the 3 tran-
scripts tested in the experiments shown in Fig. 4,
individual paired differences were not assessed. P values
of < 0.05 were considered as significant differences;
analyses were performed with SigmaStat for Windows
Version 4.0 software.
Results and discussion
We first determined the transcript expression level of 24
claudin isoforms in the whole cochlea of normal
(Slc26a4+/−) mice at three different ages after birth: P2
and P6 before the onset of endocochlear potential gener-
ation and hearing in mice, and at P15, after acquisition
of hearing. Transcripts of 21 claudin isoforms were
detected at all ages, while 3 isoforms (Cldn-16, − 17 and
− 18) were not detected (Fig. 2). The permeability prop-
erties of several isoforms have been unambiguously de-
termined [17, 18] and are shown in (Fig. 2), as described
in the figure legend. Cldn-10 [19] and Cldn-19 were
each determined for two splice variants, v1 and v2
(Table 1).
Six cochlear claudin isoforms increase with development
at P6 and/or P15: Cldn-9, − 13, − 14, − 15, and -19v2. By
contrast, Cldn-6 expression decreases with development.
Cochlear claudins that do not change significantly with de-
velopment include: Cldn-1, − 2, − 3, − 4, − 5, − 7, − 8,
−10v1, −10v2, − 11, − 12, −19v1, − 20, − 22, and − 23. As
described above, endocochlear potential normally develops
between P6 and P15. So genes that change their expression
in this period might be involved in establishment of the
special properties of the paracellular barrier of the epithelial
cells that border the endolymph, and thereby provide the
resistive barrier that supports the large endocochlear poten-
tial. Cldn-19v2 appeared to increase expression only transi-
ently during this period. The post-natal changes in
expression of multiple claudin isoforms are consistent with
the likely presence of factors that regulate claudin expres-
sion during development. Most striking of all, Cldn-13
shows a remarkably large increase in cochlear expression
compared to the others. Previously, Abuazza et al. [20] re-
ported maturational decrease of Cldn-6, − 9 and − 13 tran-
scripts and of paracellular protein in several segments of
the mouse kidney. They suggested these changes may con-
tribute to developmental changes in the paracellular perme-
ability of kidney tubules. In our study of the cochlea, Cldn-
6 undergoes developmental decrease in transcript expres-
sion from P2 to P6, and further from P6 to P15, as in the
kidney (Fig. 2). By contrast to the kidney, Cldn-9 and -13
transcripts increased from P2 to P6, and further from P6 to
P15 (Fig. 2).
The cochlear tissues expressing these claudins were re-
solved in two subsequent experimental series. In the first
series (Fig. 3a), cochleae of adult (P18-P32, mean P22.6)
Slc26a4+/− mice were subdivided into three fractions: 1)
lateral wall (exclusive of outer bone), 2) medial region,
and 3) outer bone. These fractions were assayed for 12
claudin isoforms: Cldn-5, − 6, − 7, −10v1, −10v2, − 13,
− 15, −19v1, −19v2, − 20, − 22, and − 23. All of these
claudins were detected both in the lateral wall and
the medial region fraction. Cldn-19v1 and Cldn-19v2
were expressed most strongly in the medial region.
Interestingly, Cldn-13 was expressed virtually exclu-
sively in the outer bone fraction, in spite of the statisti-
cally significant difference in the minimal expression in
the two soft tissues. Wongdee et al. examined claudin
expression in skull and tibia bone [21] and determined
localization of Cldn-5, − 11, − 14, − 15 and − 16. The ex-
pression was limited to the cells lining the bone
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Table 1 Primers for RT-PCR
Template (v: splice variant) primers sequences product length GenBank Accession Number
18S 18S_L gaggttcgaagacgatcaga 316 X00686
18S_R tcgctccaccaactaagaac
Claudin-1 cldn1L cgactccttgctgaatctga 390 NM_016674
cldn1R cgtggtgttgggtaagaggt
Claudin-2 cldn2L ggtggcttctgtgaggacat 333 NM_016675
cldn2R ctttcccttggcttcttgtg
Claudin-3 cldn3L cgggagtgcttttcctgtt 344 NM_009902
cldn3R tgctggtagtggtgacggta
Claudin-4 cldn4L3 ccgcgacttctacaacccta 326 NM_009903
cldn4R3 gtccccagcaagcagttagt
Claudin-5 cldn5L2 gaagccgtgtgtggatgac 307 NM_013805
cldn5R2 gccctttcaggttagcaggt
Claudin-6 cldn6L1 ctactgaggctgggaggatg 363 NM_ 018777
cldn6R1 ttgtgtgagcagggaagtgt
Claudin-7 cldn7L1 caactgctgggcttttcaat 329 NM_ 016887
cldn7R1 gccttcttcgctttgtcatc
Claudin-8 cldn8L4 agccggaatcatcttcttca 399 NM_018778
cldn8R4 cagtgtgggctccatttctc
Claudin-9 cldn9L2 tactccatcccttcccgttc 331 NM_ 020293
cldn9R2 ctgaggtccaggttccagag
Claudin-10v1 cldn10v1L2 gggatttttcggttccattt 378 NM_023878
cldn10v1R2 tctccttctccgccttgata
Claudin-10v2 cldn10v2L tttttcggttccatttttgc 375 NM_ 021386
cldn10v2R atctccttctccgccttgat
Claudin-11 cldn11L2 gccgaaaaatggacgaact 315 NM_008770
cldn11R2 gggcacatacaggaaaccag
Claudin-12 cldn12L3 cagatgtgctcctgttgcat 304 NM_022890
cldn12R3 cccgtgtaaatcgtcaggtt
Claudin-13 cldn13L2 tcgggaaaacaggtggatac 385 NM_020504
cldn13R2 gttgacacagagcaggatgc
Claudin-14 cldn14L3 ctgggcttcatctcctcatc 332 NM_ 019500
cldn14R3 aagagcacctccttccctgt
Claudin-15 cldn15L2 aagacggcagacaagaatcg 305 NM_021719
cldn15R2 caaagatggtgttggtggtg
Claudin-16 cldn16L1 gcagggaccacattactcatt 389 NM_053241
cldn16R1 taaacggcacaggaacacag
Claudin-17 cldn17L11 ggctgaagcagtaggccaag 314 NM_181490
cldn17R11 tgagagcaaccaaggcaaga
Claudin-18 cldn18L4 gaacccttccccaagaagag 355 NM_019815
caagctggaaaatcgaccat
Claudin-19v1 cldn19v1L gaagggctgtggatgtcttg 321 NM_001038590
cldn19v1R aggagtgctggggttgaag
Claudin-19v2 cldn19v2L2 tgctggctacatcttgtggt 306 NM_153105
cldn19v2R2 gacagttgaatggggttgct
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(periostieum), suggesting a function of claudin other
than tight junction formation. They, however, did not
test bone for the presence of Cldn-13. Johnson et al. re-
ported Cldn-13 expression in G1E cells, a proerythro-
blastic cell line [22] and Cldn-13 was identified in a
stress induced erythropoiesis pathway that is mainly
expressed in tissues associated with haematopoietic
function [23]. It is therefore likely that expression of
Cldn-13 in cochlear outer bone might originate from the
associated bone marrow, which develops during the
Table 1 Primers for RT-PCR (Continued)
Template (v: splice variant) primers sequences product length GenBank Accession Number
Claudin-20 cldn20L2 cagctccttgctttcatcct 356 NM_001101560
cldn20R2 aagcagactcctccagcaaa
Claudin-22 cldn22L2 ggcttggagagacacaggag 342 NM_029383
cldn22R2 tttctggattggcttgcttc
Claudin-23 cldn23L2 tactacagcgacggacagca 320 NM_027998
cldn23R2 cagttagaggaaggcgacca
Fig. 2 Developmental expression levels of 21 cochlear transcripts for claudin isoforms at P2, P6 and P15 in Slc26a4+/− mice. Bars for each isoform
are in chronological order, left to right; Top, middle and bottom panels are numerically-increasing isoforms. Cldn-16, − 17 and − 18 did not show
detectable specific amplification. Claudins associated with established permeability properties are designated in the second row of the labels: B,
barrier; P, permeable pore; +, cation-selective pore; −, anion-selective pore [17]. Asterisks indicate significant difference (P < 0.05) between bars
embraced by brackets using one-way ANOVA and the Holm-Sidek post-test. The absence of brackets and asterisks indicates differences are not
significant . Error bars, Standard Deviation. The individual descriptive statistics are derived from n cochleae, as indicated on the graph
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early postnatal period [15, 24]. In support of this propos-
ition, it was found that Slc26a4−/− mice exhibit delayed
bone marrow maturation between P6 and P15 [24].
Mouse Cldn-13 does not have a human homolog [3].
In the second series, cochleae of adult (P19-P28, mean
P22.0) Slc26a4+/− mice were subdivided further into four
micro-dissected fractions: 1) the stria vascularis and 2)
spiral ligament fractions were separated from the lateral
wall; 3) the organ of Corti and the 4) modiolus were sep-
arated from the medial structures. Claudins in the lateral
wall and medial fractions that gave high expression sig-
nals (claudin mRNA/18S > 4.5) in the first experimental
series (Fig. 3a) were analyzed in the more-finely sepa-
rated tissues of the second series (Fig. 3b). The epithelial
fractions (stria vascularis and organ of Corti) were found
to express Cldn-7 more strongly than their respective
primarily non-epithelial fractions, spiral ligament (fibro-
cytes) and modiolus (neurons). By contrast, the other six
isoforms did not show statistically significant differences
between the epithelial fractions and their respective adja-
cent non-epithelial fractions. Non-significant compari-
sons are not shown in Fig. 3b and comparisons other
than stria vascularis – spiral ligament and organ of
Corti – modiolus are given in the Additional file 1.
Three claudins were selected to investigate the pos-
sible effect of Slc26a4 gene deletion on inner ear devel-
opmental expression of claudins. Developmental
expression of the three isoforms demonstrated a dra-
matic postnatal increase in Cldn-13 that was not charac-
teristic of the other two claudins, consistent with the
notion that Cldn-13 is not regulated by a mechanism
common to the claudins highly expressed in the epithe-
lial tissues. We examined RNA from whole cochleae
from age- and sex-matched littermates of Slc26a4+/− and
Slc26a4−/− and analyzed by two-way ANOVA 1) Cldn-
11, which is expressed in basal cells of stria vascularis
[12], and whose deletion in mice causes hearing loss, 2)
Cldn-13, which is expressed in cochlear outer bone (this
report), and 3) Cldn-14, which is expressed in organ of
Corti and is responsible for human hereditary deafness
DFNB29. The results of analysis (Fig. 4) showed no sta-
tistically significant interaction between age and geno-
type in all three genes and no further comparisons of
individual paired genotypes were made.
Fig. 3 Localization of selected claudin isoforms (see text) in the cochlea. a The cochlea was dissected into three parts (lateral wall, medial region
and outer bone). Transcript expression is shown for cldn-5, − 6, − 7, −10v1, −10v2, − 13, − 15, −19v1, −19v2, − 20, − 22, − 23 (n = 3) in each fraction.
Ages of samples are between P18 and P32 (days), mean: 22.6. Asterisks indicate significant difference between tissues. Claudins in the lateral wall
and medial fractions that were highly expressed (claudin mRNA/18S > 4.5; dashed line) in this experimental series were analyzed in the
more-finely separated tissues of the following series. b The lateral and medial fractions were each subdivided into two smaller fractions
in order to obtain finer resolution of location (n = 6). Lateral wall: stria vascularis and spiral ligament; Medial region: organ of Corti and
modiolus. Ages of samples are between P19 and P28 (days), mean: 22.0. Asterisks indicate significant difference (P < 0.05) using the two-way
analysis of variance as indicated by brackets; *, significant. Non-significant comparisons are not shown and comparisons other than stria vascularis –
spiral ligament and organ of Corti – modiolus are given in the Additional file 1. Error bars, Standard Deviation
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“Cldn-21” was not included in this study. The nomencla-
ture has varied and developed since 2001 and was not iden-
tified in mouse at the time of this study [25]. The mouse
gene currently accepted as Cldn-21 [25, 26] has been heter-
ologously expressed in MDCK epithelial cell cultures,
immunolocalized to sites that also express the tight-
junction protein occludin, and was shown to participate in
a Na+-selective paracellular transport pathway [26].
Some of our data differ from previous observations:
expression of Cldn-5, − 6 and − 15 was not detected by
Kitajiri et al. [12], but were observed in our experiments.
In kidney, Cldn-5 and -15 are expressed in endothelial
cells, not epithelial cells [27]. By contrast, Kitajiri et al.
[12] reported that there had been no expression of Cldn-
5 and Cldn-15 in stria vascularis nor spiral ligament,
both highly vascularized tissues. We found Cldn-6 ex-
pression, but it gradually decreased during early devel-
opment. Consistent with our observation, Kitajiri et al.
[12] did not see any expression of Cldn-6 in the adult
cochlea.
Conclusions
We analyzed 24 claudins in structures of the inner ear.
Previous studies did not show the presence and
localization of Cldn-7, Cldn-13, Cldn-19 to − 23 in the
cochlea, but the results of our study showed regional
localization of transcripts of these genes in the cochlea
and developmental changes in two of them. We ob-
served that Cldn-13 is expressed in bone and that its ex-
pression increased rapidly during early postnatal
development. Most of the claudins were expressed in
stria vascularis and organ of Corti, tissue fractions rich
in tight junctions. However, this study suggests a novel
function of Cldn-13 in the cochlea, which may be linked
to cochlear bone marrow maturation.
Additional file
Additional file 1: “Claudin expression raw data”. This file contains the
data points collected and analyzed in the text and figures. (XLSX 86 kb)
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